STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $400,000 | -66.5% | 196,365 | -51.2% | 0.00% | – |
| Q2 2021 | $1,195,000 | +930.2% | 402,297 | +857.9% | 0.00% | – |
| Q1 2021 | $116,000 | +107.1% | 41,998 | +82.4% | 0.00% | – |
| Q4 2020 | $56,000 | -17.6% | 23,023 | -28.7% | 0.00% | – |
| Q3 2020 | $68,000 | -43.8% | 32,303 | +0.9% | 0.00% | – |
| Q2 2020 | $121,000 | +157.4% | 32,009 | +29.2% | 0.00% | – |
| Q1 2020 | $47,000 | -33.8% | 24,766 | -27.7% | 0.00% | – |
| Q4 2019 | $71,000 | +1.4% | 34,240 | +16.4% | 0.00% | – |
| Q3 2019 | $70,000 | -20.5% | 29,426 | +4.9% | 0.00% | – |
| Q2 2019 | $88,000 | -81.7% | 28,039 | -70.9% | 0.00% | – |
| Q1 2019 | $480,000 | +451.7% | 96,342 | +398.2% | 0.00% | – |
| Q4 2018 | $87,000 | -85.3% | 19,338 | -84.1% | 0.00% | – |
| Q3 2018 | $590,000 | -74.7% | 121,587 | -68.7% | 0.00% | -100.0% |
| Q2 2018 | $2,330,000 | +756.6% | 388,395 | +1163.0% | 0.00% | – |
| Q1 2018 | $272,000 | 0.0% | 30,752 | -18.1% | 0.00% | – |
| Q4 2017 | $272,000 | – | 37,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |